Obeticholic Acid Versus Placebo, in Combination with Ursodeoxycholic Acid in Patients with Primary Biliary Cirrhosis
Clinical trial NCT06715319 · COMPLETED
Trial details
- NCT number
- NCT06715319
- Sponsor
- Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-09
- Primary completion
- 2023-10-16
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.